Skip to main navigation
Zymeworks Logo Zymeworks Logo

Client Header Links

  • Patients
    • Trials
    • Expanded Access
  • Pipeline
    • Zanidatamab
    • ZW49
    • Preclinical & Advanced Discovery
    • Partnerships
    • Publications
  • Partners
  • Technology
    • Azymetric™
    • ZymeLink™
    • EFECT™
    • ProTECT™
    • Science
  • Careers
    • Apply
    • Perks & Benefits
    • Corporate Gallery
  • About
  • Investors & Media

Investor Relations

  • Home
  • Stock Info
    • Stock Quote & Chart
    • Historic Price Lookup
    • Analyst Coverage
  • Events & Presentations
  • Financial Documents
  • Press Releases
  • Leadership
  • Governance
    • Governance Documents
    • Committees
    • Ethics Reporting
  • Investor Info
    • Contact Us
    • Email Alerts
    • FAQs

SEC Filing Details

SEC Filing Details

Document Details

Form
D/A
Filing Date
04/21/2014
Document Date
04/21/2014
Form Description
Notice of Exempt Offering of Securities - amendment
Filing Group
Other
Company
Zymeworks Inc.
Issuer
ZYMEWORKS INC.

Filing Formats

View HTML
Download PDF
Download DOC
Copyright 2022 , Zymeworks Inc. 
Zymeworks Logo

Client Footer Links

  • Technology
    • Azymetric™
    • ZymeLink™
    • EFECT™
    • Science
  • Pipeline
    • Zanidatamab
    • ZW49
    • Preclinical Candidates
    • Partnerships
    • Publications
    • For Patients
  • Investors
    • Stock Info
    • Press Releases
    • Events & Presentations
    • Financials
    • Governance
  • Corporate
    • Leadership
    • Board of Directors
    • Careers
    • Legal
    • Privacy
    • Contact
  • Twitter
  • LinkedIn